Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOOKAD Soluble VTP vs Active Surveillance in Low-Risk Localised Prostate Cancer
2010-021900-93Phase 3Completed
- Sponsor
- Steba Biotech
- Start
- Aug 2010
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of talaporfin sodium in prostate cancer (PCa) (2 arms), sponsored by Steba Biotech. Started Aug 2010; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2010-021900-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021900-93.